Publication: Anti-Hav Total Prevalence in Inactive Hepatitis B Carriers and in Patients with Chronic Hepatitis B, C and D
| dc.authorwosid | Ataman Hati̇poğlu, Çiğdem/Aaa-4135-2021 | |
| dc.authorwosid | Tulek, Necla/M-3283-2017 | |
| dc.authorwosid | Ertem, Gunay/Grj-7397-2022 | |
| dc.authorwosid | Yetkin, Meltem/Gqb-0055-2022 | |
| dc.authorwosid | Kinikli, Sami/Iyj-9555-2023 | |
| dc.authorwosid | Ataman Hatipoğlu, Çiğdem/Aaa-4135-2021 | |
| dc.contributor.author | Hatipoglu, Cigdem Ataman | |
| dc.contributor.author | Kinikli, Sami | |
| dc.contributor.author | Koruk, Suda Tekin | |
| dc.contributor.author | Arica, Nese Ates | |
| dc.contributor.author | Ertem, Gunay Tuncer | |
| dc.contributor.author | Yetkin, M. Arzu | |
| dc.contributor.author | Demiroz, Ali Pekcan | |
| dc.contributor.authorID | Ataman Hati̇poğlu, Çiğdem/0000-0002-1104-8232 | |
| dc.contributor.authorID | Tuncer Ertem, Gunay/0000-0001-8760-0030 | |
| dc.date.accessioned | 2025-12-11T01:21:59Z | |
| dc.date.issued | 2005 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Hatipoglu, Cigdem Ataman; Kinikli, Sami; Koruk, Suda Tekin; Arica, Nese Ates; Ertem, Gunay Tuncer; Yetkin, M. Arzu; Demiroz, Ali Pekcan] SB Ankara Egitim & Arafltirma Hastanesi, Nfeksiyon Hastaliklari & Klin Mikrobiyoloji Klin, Ankara, Turkey; [Tulek, Necla] Ondokuz Mayis Univ, Tip Fak, Nfeksiyon Hastaliklari &Klin Mikrobiyoloji Anabil, Samsun, Turkey | en_US |
| dc.description | Ataman Hati̇poğlu, Çiğdem/0000-0002-1104-8232; Tuncer Ertem, Gunay/0000-0001-8760-0030; | en_US |
| dc.description.abstract | Hepatitis A virus (HAV) infection is a worldwide health problem, but rarely causes fatal fulminan hepatitis. HAV infection in patients with chronic liver diseases is associated with increased rate of fulminan hepatitis and mortality. Vaccination against HAV is recommended for patients with underlying chronic liver disease who are negative for anti-HAV antibody. In this study, a total of 780 patients (680 inactive hepatitis B virus carrier, 62 chronic hepatitis C, 34 chronic hepatitis B, 4 chronic hepatitis D) were tested for the presence of anti-HAV total antibody. Anti-HAV seroprevalence was found 93.7%. | en_US |
| dc.description.woscitationindex | Emerging Sources Citation Index | |
| dc.identifier.endpage | 168 | en_US |
| dc.identifier.issn | 1307-9441 | |
| dc.identifier.issn | 2147-2939 | |
| dc.identifier.issue | 3 | en_US |
| dc.identifier.startpage | 164 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/43276 | |
| dc.identifier.volume | 10 | en_US |
| dc.identifier.wos | WOS:000217138900007 | |
| dc.language.iso | tr | en_US |
| dc.publisher | Galenos Yayincilik | en_US |
| dc.relation.ispartof | Viral Hepatit Dergisi-Viral Hepatitis Journal | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Hepatitis A Virus Infection | en_US |
| dc.subject | Seroprevalence | en_US |
| dc.subject | Chronic Viral Hepatitis | en_US |
| dc.title | Anti-Hav Total Prevalence in Inactive Hepatitis B Carriers and in Patients with Chronic Hepatitis B, C and D | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication |
